Skip to main content

Follistatin vs CJC-1295

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Follistatin

Follistatin is a glycoprotein that inhibits myostatin, the protein responsible for limiting muscle growth. By blocking myostatin, follistatin can theoretically allow for increased muscle development beyond natural limits.

Full details →

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

Side-by-Side Comparison

AspectFollistatinCJC-1295
MechanismBinds to and neutralizes myostatin and activin, both of which are negative regulators of muscle mass. This removes the natural brake on muscle growth, allowing for enhanced hypertrophy.CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.
Typical DosageResearch protocols typically use 100-300mcg daily, though optimal dosing is not well established. Gene therapy approaches have also been studied.CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.
AdministrationSubcutaneous injection. Different isoforms exist (FS344, FS315) with varying properties. Requires careful sourcing due to complexity.Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.
Side EffectsLimited human data. Theoretical concerns about effects on other organs where activin signaling is important.Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.
Best For

What They Have in Common

Both Follistatin and CJC-1295 are commonly used for:

Key Differences

Unique to CJC-1295:

Detailed Analysis

Both CJC-1295 and Follistatin are commonly used for Muscle Growth.

Which Should You Choose?

CJC-1295 has stronger evidence for Muscle Growth.

Ready to Learn More?